These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 24751910)

  • 1. A role for the gut microbiota in IBS.
    Collins SM
    Nat Rev Gastroenterol Hepatol; 2014 Aug; 11(8):497-505. PubMed ID: 24751910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbiota and irritable bowel syndrome].
    Ducrotté P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota as potential orchestrators of irritable bowel syndrome.
    Bennet SM; Ohman L; Simren M
    Gut Liver; 2015 May; 9(3):318-31. PubMed ID: 25918261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
    Shanahan F; Quigley EM
    Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
    Fukudo S
    Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered intestinal microbiota in irritable bowel syndrome.
    Lee KJ; Tack J
    Neurogastroenterol Motil; 2010 May; 22(5):493-8. PubMed ID: 20414959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
    Ohman L; Simrén M
    Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intestinal Microbiota and Irritable Bowel Syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota, diet and health.
    Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF
    Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.